372 related articles for article (PubMed ID: 23486877)
1. Molecular and pathologic insights from latent HIV-1 infection in the human brain.
Desplats P; Dumaop W; Smith D; Adame A; Everall I; Letendre S; Ellis R; Cherner M; Grant I; Masliah E
Neurology; 2013 Apr; 80(15):1415-23. PubMed ID: 23486877
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of BCL11B and its recruited chromatin remodeling factors during highly active antiretroviral therapy synergistically represses the transcription of human immunodeficiency virus type 1 and is associated with residual immune activation.
Wang J; Yang Z; Wu NP; Yang J
Arch Virol; 2020 Feb; 165(2):321-330. PubMed ID: 31828511
[TBL] [Abstract][Full Text] [Related]
3. The cost of silencing HIV in the brain.
Wiley CA; Cysique LA
Neurology; 2013 Apr; 80(15):1363-4. PubMed ID: 23486870
[No Abstract] [Full Text] [Related]
4. The relationship between HIV-1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post-mortem brain tissue.
Williams ME; Naudé PJW
Rev Med Virol; 2024 Jan; 34(1):e2519. PubMed ID: 38282400
[TBL] [Abstract][Full Text] [Related]
5. Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons.
Mukhtar M; Acheampong E; Khan MA; Bouhamdan M; Pomerantz RJ
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):48-57. PubMed ID: 15857668
[TBL] [Abstract][Full Text] [Related]
6. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis.
Masliah E; Roberts ES; Langford D; Everall I; Crews L; Adame A; Rockenstein E; Fox HS
J Neuroimmunol; 2004 Dec; 157(1-2):163-75. PubMed ID: 15579294
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain.
Lamers SL; Salemi M; Galligan DC; Morris A; Gray R; Fogel G; Zhao L; McGrath MS
J Neurovirol; 2010 May; 16(3):230-41. PubMed ID: 20367240
[TBL] [Abstract][Full Text] [Related]
8. Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model.
Gavegnano C; Haile W; Koneru R; Hurwitz SJ; Kohler JJ; Tyor WR; Schinazi RF
J Neurovirol; 2020 Dec; 26(6):838-845. PubMed ID: 32901392
[TBL] [Abstract][Full Text] [Related]
9. Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy.
Fischer-Smith T; Croul S; Adeniyi A; Rybicka K; Morgello S; Khalili K; Rappaport J
Am J Pathol; 2004 Jun; 164(6):2089-99. PubMed ID: 15161643
[TBL] [Abstract][Full Text] [Related]
10. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.
Gelman BB; Lisinicchia JG; Morgello S; Masliah E; Commins D; Achim CL; Fox HS; Kolson DL; Grant I; Singer E; Yiannoutsos CT; Sherman S; Gensler G; Moore DJ; Chen T; Soukup VM
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):487-95. PubMed ID: 23242157
[TBL] [Abstract][Full Text] [Related]
11. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis.
Persidsky Y; Buttini M; Limoges J; Bock P; Gendelman HE
J Neurovirol; 1997 Dec; 3(6):401-16. PubMed ID: 9475112
[TBL] [Abstract][Full Text] [Related]
12. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
Achim CL; Adame A; Dumaop W; Everall IP; Masliah E;
J Neuroimmune Pharmacol; 2009 Jun; 4(2):190-9. PubMed ID: 19288297
[TBL] [Abstract][Full Text] [Related]
13. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss.
Archibald SL; Masliah E; Fennema-Notestine C; Marcotte TD; Ellis RJ; McCutchan JA; Heaton RK; Grant I; Mallory M; Miller A; Jernigan TL
Arch Neurol; 2004 Mar; 61(3):369-76. PubMed ID: 15023814
[TBL] [Abstract][Full Text] [Related]
14. Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection.
Kuster H; Opravil M; Ott P; Schlaepfer E; Fischer M; Günthard HF; Lüthy R; Weber R; Cone RW
Am J Pathol; 2000 Jun; 156(6):1973-86. PubMed ID: 10854220
[TBL] [Abstract][Full Text] [Related]
15. Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.
Wheeler ED; Achim CL; Ayyavoo V
J Neurovirol; 2006 Jun; 12(3):200-10. PubMed ID: 16877301
[TBL] [Abstract][Full Text] [Related]
16. Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier.
Nakagawa S; Castro V; Toborek M
J Cell Mol Med; 2012 Dec; 16(12):2950-7. PubMed ID: 22947176
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation.
Hussain A; Wesley C; Khalid M; Chaudhry A; Jameel S
J Virol; 2008 Jan; 82(2):893-902. PubMed ID: 17959659
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.
Dallasta LM; Pisarov LA; Esplen JE; Werley JV; Moses AV; Nelson JA; Achim CL
Am J Pathol; 1999 Dec; 155(6):1915-27. PubMed ID: 10595922
[TBL] [Abstract][Full Text] [Related]
19. Cytokine expression in the brain during the acquired immunodeficiency syndrome.
Tyor WR; Glass JD; Griffin JW; Becker PS; McArthur JC; Bezman L; Griffin DE
Ann Neurol; 1992 Apr; 31(4):349-60. PubMed ID: 1586135
[TBL] [Abstract][Full Text] [Related]
20. Functional roles of HIV-1 Vpu and CD74: Details and implications of the Vpu-CD74 interaction.
Le Noury DA; Mosebi S; Papathanasopoulos MA; Hewer R
Cell Immunol; 2015; 298(1-2):25-32. PubMed ID: 26321123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
